文献速递哮喘呼吸道感染

17q21变异干扰儿童哮喘的黏膜宿主防御

17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究对ALLIANCE队列中261名儿童(78名健康、79名学龄前喘息、104名哮喘)的鼻刷样本进行全基因组转录组分析,探索17q21基因型(SNP rs72163891)的影响,并检测鼻分泌物IFN蛋白水平。结果发现17q21风险等位基因诱导黏膜GSDMB表达增强,与细胞溶解性免疫反应激活及IFN类型1和3表达降低相关,揭示了该位点增加早期呼吸道病毒感染易感性的新机制。

要点

  • 17q21风险等位基因诱导黏膜GSDMB表达增强,且呈基因型及哮喘/喘息表型依赖性。
  • GSDMB表达增加与细胞溶解性免疫反应及自然杀伤细胞特征激活相关。
  • 黏膜IFN类型1和3表达在mRNA和蛋白水平均降低,提示气道免疫能力受损。

核心结论

  • 17q21风险等位基因通过增加黏膜GSDMB表达,诱发细胞溶解性免疫反应并损害气道免疫能力,从而增加早期呼吸道病毒感染易感性。

研究设计与样本

  • 在ALLIANCE队列中对261名儿童(78名健康、79名学龄前喘息、104名哮喘)的鼻刷样本进行全基因组转录组分析,中位年龄10.0岁(范围1.0-20.0),并检测鼻分泌物IFN蛋白水平。

主要发现

  • 17q21风险等位基因诱导黏膜GSDMB表达增强,且为学龄前喘息儿童中唯一相关的17q21编码基因。
  • GSDMB表达增加与类型1促炎、细胞溶解性免疫及自然杀伤细胞特征激活相关,包括IFNG、CXCL9、CXCL10、KLRC1、CD8A、GZMA等基因。
  • IFN类型1和3表达特征在mRNA和蛋白水平均降低。

临床怎么用

  • 提示GSDMB相关气道细胞死亡及黏膜IFN特征紊乱是17q21风险等位基因携带者早期易感呼吸道病毒感染的机制,为未来生物干预提供新方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The strongest genetic risk factor for childhood-onset asthma, the 17q21 locus, is associated with increased viral susceptibility and disease-promoting processes.Objectives: To identify biological targets underlying the escalated viral susceptibility associated with the clinical phenotype mediated by the 17q21 locus.Methods: Genome-wide transcriptome analysis of nasal brush samples from 261 children (78 healthy, 79 with wheezing at preschool age, 104 asthmatic) within the ALLIANCE (All-Age-Asthma) cohort, with a median age of 10.0 (range, 1.0-20.0) years, was conducted to explore the impact of their 17q21 genotype (SNP rs72163891). Concurrently, nasal secretions from the same patients and visits were collected, and high-sensitivity mesoscale technology was employed to measure IFN protein levels.Measurements and Main Results: This study revealed that the 17q21 risk allele induces a genotype- and asthma/wheeze phenotype-dependent enhancement of mucosal GSDMB expression as the only relevant 17q21-encoded gene in children with preschool wheeze. Increased GSDMB expression correlated with the activation of a type-1 proinflammatory, cell-lytic immune, and natural killer signature, encompassing key genes linked to an IFN type-2-signature (IFNG, CXCL9, CXCL10, KLRC1, CD8A, GZMA). Conversely, there was a reduction in IFN type 1 and type 3 expression signatures at the mRNA and protein levels.Conclusions: This study demonstrates a novel disease-driving mechanism induced by the 17q21 risk allele. Increased mucosal GSDMB expression is associated with a cell-lytic immune response coupled with compromised airway immunocompetence. These findings suggest that GSDMB-related airway cell death and perturbations in the mucosal IFN signature account for the increased vulnerability of 17q21 risk allele carriers to respiratory viral infections during early life, opening new options for future biological interventions.The All-Age-Asthma (ALLIANCE) cohort is registered at www.clinicaltrials.gov (pediatric arm, NCT02496468).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Jakwerth CA, Weckmann M, Illi S, et al. 17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma. Am J Respir Crit Care Med. 2024. PMID: 38064241. doi:10.1164/rccm.202305-0934OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。